Technology
Health
Biotechnology

Paratek Pharmaceuticals

$3.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.25 (-6.93%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell PRTK and other stocks, options, ETFs, and crypto commission-free!

About PRTK

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. Read More The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.

Employees
104
Headquarters
Boston, Massachusetts
Founded
1996
Market Cap
117.02M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
232.07K
High Today
$3.67
Low Today
$3.29
Open Price
$3.61
Volume
332.70K
52 Week High
$12.30
52 Week Low
$3.29

Collections

Technology
Health
Biotechnology
US
North America

PRTK Earnings

-$1.19
-$1.01
-$0.82
-$0.64
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.